Background Helicobacter pylori is one of the most prevalent global pathogens and can lead
to gastrointestinal disease including peptic ulcers, gastric marginal zone lymphoma and …

Management of Helicobacter pylori infection is evolving and in this 4th edition of the
Maastricht consensus report aspects related to the clinical role of H pylori were looked at …

Helicobacter pylori (H. pylori) infection is highly prevalent in the human population and may
lead to severe gastrointestinal pathology including gastric and duodenal ulcers, mucosa …

Significant progress and new insights have been gained in the 4 years since the first
Maastricht Consensus Report, necessitating an update of the original guidelines. To achieve …

Background Thousands of systematic reviews have been conducted in all areas of health
care. However, the methodological quality of these reviews is variable and should routinely …

Helicobacter pylori is a major human pathogen. Diagnosis of H. pylori infection and
determination of its antibiotic susceptibility still mainly rely on culture and phenotypic drug …

In this critical review, plant sources used as effective antibacterial agents against
Helicobacter pylori infections are carefully described. The main intrinsic bioactive molecules …

Helicobacter pylori (H. pylori) is a Gram-negative bacterium that colonizes the gastric
mucosa and is associated with various gastrointestinal disorders. H. pylori is a pervasive …

Background As with any other infectious disease, we should aim for treatments offering≥
90% Helicobacter pylori eradication rates in clinical practice. Aim To summarize optimization …

Erythromycin, the first macrolide antibiotic discovered, has been used since the early 1950s
for the treatment of upper respiratory tract and skin and soft tissue infections caused by …